PuSH - Publikationsserver des Helmholtz Zentrums München

Karch, A.* ; Vogelmeier, C.* ; Welte, T.* ; Bals, R.* ; Kauczor, H.U.* ; Biederer, J.* ; Heinrich, J. ; Schulz, H. ; Gläser, S.* ; Holle, R. ; Watz, H.* ; Korn, S.* ; Adaskina, N.* ; Biertz, F.* ; Vogel, C.* ; Vestbo, J.* ; Wouters, E.F.M.* ; Rabe, K.F.* ; Söhler, S.* ; Koch, A.* ; Jörres, R.A.*

The German COPD cohort COSYCONET: Aims, methods and descriptive analysis of the study population at baseline.

Respir. Med. 114, 27-37 (2016)
Verlagsversion Postprint DOI PMC
Open Access Green
Background The German COPD cohort study COSYCONET ("COPD and SYstemic consequences-COmorbidities NETwork") investigates the interaction of lung disease, comorbidities and systemic inflammation. Recruitment took place from 2010 to 2013 in 31 study centers. In addition to the baseline visit, follow-up visits are scheduled at 6, 18, 36 and 54 months after baseline. The study also comprises a biobank, image bank, and includes health economic data. Here we describe the study design of COSYCONET and present baseline data of our COPD cohort. Methods Inclusion criteria were broad in order to cover a wide range of patterns of the disease. In each visit, patients undergo a large panel of assessments including e.g. clinical history, spirometry, body plethysmography, diffusing capacity, blood samples, 6-min walk-distance, electrocardiogram and echocardiography. Chest CTs are collected if available and CTs and MRIs are performed in a subcohort. Data are entered into eCRFs and subjected to several stages of quality control. Results Overall, 2741 subjects with a clinical diagnosis of COPD were included (59% male; mean age 65 ± 8.6 years (range 40-90)). Of these, 8/35/32/9% presented with GOLD stages I-IV; 16% were uncategorized, including the former GOLD-0 category. 24% were active smokers, 68% ex-smokers and 8% never-smokers. Data completeness was 96% for the baseline items. Conclusion The German COPD cohort comprises patients with advanced and less advanced COPD. This is particularly useful for studying the time course of COPD in relation to comorbidities. Baseline data indicate that COSYCONET offers the opportunity to investigate our research questions in a large-scale, high-quality dataset.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
3.036
1.356
76
77
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Cohort ; Comorbidity ; Copd ; Study Design ; Systemic Inflammation; Obstructive Pulmonary-disease; Air-flow Limitation; Quality-of-life; Systemic Inflammation; General-population; Lung-function; Gold Classification; Reference Values; Body-mass; Comorbidities
Sprache
Veröffentlichungsjahr 2016
HGF-Berichtsjahr 2016
ISSN (print) / ISBN 0954-6111
e-ISSN 1532-3064
Zeitschrift Respiratory Medicine
Quellenangaben Band: 114, Heft: , Seiten: 27-37 Artikelnummer: , Supplement: ,
Verlag Elsevier
Verlagsort London
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Epidemiology (EPI)
Institute of Health Economics and Health Care Management (IGM)
POF Topic(s) 30503 - Chronic Diseases of the Lung and Allergies
30202 - Environmental Health
80000 - German Center for Lung Research
Forschungsfeld(er) Genetics and Epidemiology
PSP-Element(e) G-503900-003
G-503900-001
G-505300-002
G-501800-391
Scopus ID 84961774661
PubMed ID 27109808
Erfassungsdatum 2016-04-14